SHANGHAI, Oct. 21, 2014 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, with operations in China and the United States, today announced that it will release financial results for the third quarter of 2014 after the New York Stock Exchange closes on Wednesday, November 12, 2014 (which will be Thursday morning, November 13, 2014 Shanghai time). The earnings release will be available on the investor relations section of the Company’s website at http://www.wuxiapptec.com/.

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 9:00 pm (Beijing/Shanghai/Hong Kong) on Thursday, November 13, 2014, to discuss the third-quarter 2014 financial results and recent business activities. The conference call may be accessed by calling:

Mainland China                               4001 200 539

Hong Kong                                     800 905 927

Singapore                                    800 616 3222

United Kingdom                               0800 015 9725

United States                               1855 298 3404

United States-New York (toll)             +1 631 5142 526

Other countries (toll)                       +65 6823 2299

Conference ID                                     7520886

A telephone replay will be available two hours after the call’s completion at:

Mainland China                               4001 842 240

Hong Kong                                     800 966 697

Singapore                                     800 616 2127

United Kingdom                               0800 169 7301

United States                               1866 846 0868

Conference ID                                     7520886

A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech’s website at http://www.wuxiapptec.com/.

About WuXi PharmaTech

WuXi PharmaTech is a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech’s services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

For more information, please contact:

Ronald Aldridge

Director of Investor Relations

WuXi PharmaTech (Cayman) Inc.

Tel: +1-201-585-2048

Email: [email protected]

Web: http://www.wuxiapptec.com

END

IMAGE: www.wuxiapptec.com